Abstract:
The present invention relates to compounds and methods for inhibiting the expression of vascular endothelial growth factor-C (VEGF-C) in a target cell. Particularly, the present invention relates to antisense polynucleotides complementary to a lens epithelium-derived growth factor (LEDGF/p75) mRNA and uses thereof for inhibiting tumor progression and tumor metastasis. The present invention further relates to uses of LEDGF/p75 polypeptide or a nucleic acid encoding same for treating endothelial cell related conditions, particularly inflammation and edema.
Abstract:
The invention provides a method for determining the presence of leptin, based on detecting leptin-induced angiopoietin-2 expression in some cells or cell lines, e.g. murine Swiss 3T3 F442A preadipocytes or human marrow stromal cell line hMS2-12. Leptin detection is e.g. performed transfecting cells with a vector comprising a reporter gene (e.g. Green Fluorescent Protein (GFP)) under the control of angiopoietin-2 promoter.